DataKnowledgeCloudtrainingcoordination

L1000 LINCS DCIC FIBR042 MCLF0067SZ 6H C08 fumonisin-b1 0.04uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF0067SZ

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR042 MCLF0067SZ 6H C08 fumonisin-b1 0.04uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:311 KB

Size In Bytes:127 KB

Sha256:b1009a12bbf9db8316e5c35494151a7792380d98924511699bab8b4414ad5a3e

Persistent Id:drs://drs.lincs-dcic.org/d9f2f94b1fd21a5605b4ace2aedff357

Mime Type:application/gzip

Md5:d9f2f94b1fd21a5605b4ace2aedff357

Filename:L1000_LINCS_DCIC_FIBR042_MCLF0067SZ_6H_C08_fumonisin-b1_0.04uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/d9f2f94b1fd21a5605b4ace2aedff357

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR042 MCLF0067SZ 6H C08 fumonisin-b1 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR042 MCLF0067SZ 6H C08 fumonisin-b1 0.04uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.